Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Insight Molecular Diagnostics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 89 | −5 |
| Shares | 56.6M | 312 | 55.4M | −1.13M (−2.0%) |
| Value | $201.9M | $1.00K | $120.1M | −$81.7M (−40.5%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 252,298 | $547.0K | 0.07% |
| Wealth Effects LLC | 43,500 | $94.0K | 0.04% |
| Allspring Global Investments Holdings, LLC | 26,869 | $58.0K | 0.00% |
| ProShare Advisors LLC | 26,136 | $56.0K | 0.00% |
| MML Investors Services, LLC | 25,500 | $55.0K | 0.00% |
| Creative Planning | 15,309 | $33.0K | 0.00% |
| Williams Jones Wealth Management, LLC. | 15,000 | $33.0K | 0.00% |
| Freestone Capital Holdings, LLC | 10,000 | $22.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 690 | $1.00K | 0.00% |
| CWM, LLC | 100 | $0 | 0.00% |
| Carroll Investors, Inc | 300 | $0 | 0.00% |
| CoreCap Advisors, LLC | 5 | – | – |
Sold out (17)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| GW&K Investment Management, LLC | 781,789 | $2.78M |
| Millrace Asset Group, Inc. | 613,885 | $2.19M |
| Marshall Wace, LLP | 63,216 | $225.0K |
| Colonial River Wealth Management, LLC | 66,200 | $218.0K |
| Ergoteles LLC | 42,300 | $151.0K |
| State Board of Administration of Florida Retirement System | 22,947 | $82.0K |
| Raymond James Financial Services Advisors, Inc. | 15,749 | $56.0K |
| Amalgamated Bank | 11,514 | $41.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 11,126 | $40.0K |
| Principal Financial Group Inc | 10,674 | $38.0K |
| Meeder Asset Management Inc | 3,948 | $14.0K |
| Agf Investments Inc. | 2,571 | $9.00K |
| Liberty Wealth Management LLC | 1,000 | $4.00K |
| Simplex Trading, LLC | 397 | $2.00K |
| The PNC Financial Services Group, Inc. | 302 | $1.00K |
| Parallel Advisors, LLC | 222 | $1.00K |
| Ellevest, Inc. | 67 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 312 | $1.00K |